Skip to main content
. 2017 Feb 28;23(8):1489–1496. doi: 10.3748/wjg.v23.i8.1489

Figure 3.

Figure 3

Comparison of the infliximab trough levels between patients with/without antibody to infliximab. In the ATI-negative and -positive groups, the median infliximab trough levels (IFX-TLs) were 1.415 μg/mL (IQR 0.570-2.495) and 0.141 μg/mL (IQR 0.002-0.869), respectively (P < 0.001). ATI: Antibodies to infliximab.